Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Korting

Showing results (221-230 of 341) with videos related to

Pageof 35
Sort By:
Antimicrobial Agents and Chemotherapy|January 1, 1990
Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersR Warlich, H C Korting, M Schäfer-Korting, et al.
International Journal of STD & AIDS|May 1, 1993
The suppressive effect of serum samples from patients with chancroid on human mononuclear cells correlates with the clinical picture and is interleukin-2-dependentH C Korting, R Zaba, R C Ballard, et al.
Journal of the American Academy of Dermatology|December 1, 1991
Topical liposome drugs to come: what the patent literature tells us. A reviewH C Korting, P Blecher, M Schäfer-Korting, et al.
European Journal of Clinical Pharmacology|October 1, 1982
Does cantharides blister fluid provide access to the peripheral compartment?M Schäfer-Korting, H C Korting, S Hiemstra, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996
0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effectsM J Kerscher, H C Korting, L Mehringer, et al.
The Journal of Infection|November 20, 1998
A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatmentH C Korting, U Patzak, M Schaller, et al.
Mycoses|August 26, 1998
Shift from persistent oral pseudomembranous to erythematous candidosis in a human immunodeficiency virus (HIV)-infected patient upon combination treatment with an HIV protease inhibitorL Hoegl, E Thoma-Greber, M Röcken, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1981
[Amiodarone pigmentation. A rare, but typical drug side-effect]H C Korting, R Kolz, C Schmoeckel, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgarisH C Korting, H Zienicke, M Schäfer-Korting, et al.
The Journal of Investigative Dermatology|March 25, 2000
Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermisM Schaller, C Schackert, H C Korting, et al.
Pageof 35

Showing results (221-230 of 341) with videos related to

Sort By:
Pageof 35
Antimicrobial Agents and Chemotherapy|January 1, 1990
Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteersR Warlich, H C Korting, M Schäfer-Korting, et al.
International Journal of STD & AIDS|May 1, 1993
The suppressive effect of serum samples from patients with chancroid on human mononuclear cells correlates with the clinical picture and is interleukin-2-dependentH C Korting, R Zaba, R C Ballard, et al.
Journal of the American Academy of Dermatology|December 1, 1991
Topical liposome drugs to come: what the patent literature tells us. A reviewH C Korting, P Blecher, M Schäfer-Korting, et al.
European Journal of Clinical Pharmacology|October 1, 1982
Does cantharides blister fluid provide access to the peripheral compartment?M Schäfer-Korting, H C Korting, S Hiemstra, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996
0.05% clobetasol 17-propionate cream and ointment but not the corresponding 0.1% triamcinolone acetonide preparations increase skin surface roughness: a possible dissociation of unwanted epidermal and dermal effectsM J Kerscher, H C Korting, L Mehringer, et al.
The Journal of Infection|November 20, 1998
A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatmentH C Korting, U Patzak, M Schaller, et al.
Mycoses|August 26, 1998
Shift from persistent oral pseudomembranous to erythematous candidosis in a human immunodeficiency virus (HIV)-infected patient upon combination treatment with an HIV protease inhibitorL Hoegl, E Thoma-Greber, M Röcken, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|June 1, 1981
[Amiodarone pigmentation. A rare, but typical drug side-effect]H C Korting, R Kolz, C Schmoeckel, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgarisH C Korting, H Zienicke, M Schäfer-Korting, et al.
The Journal of Investigative Dermatology|March 25, 2000
Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermisM Schaller, C Schackert, H C Korting, et al.
Pageof 35